CAR T cell therapy: newer approaches to counter resistance and cost

The genetically engineered Chimeric Antigen Receptor bearing T-cell (CAR T cell) therapy has been emerged as the new paradigm of cancer immunotherapy. However, recent studies have reported an increase in the number of relapsed haematological malignancies. This review provides newer insights into how...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Rajesh Kumar, Ali, Asgar, Kumar, Santosh, Sharma, Alpana, Baghchi, Basab, Singh, Pritanjali, Das, Sushmita, Singh, Chandramani, Sharma, Sadhana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171532/
https://www.ncbi.nlm.nih.gov/pubmed/32322738
http://dx.doi.org/10.1016/j.heliyon.2020.e03779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171532/
https://www.ncbi.nlm.nih.gov/pubmed/32322738
http://dx.doi.org/10.1016/j.heliyon.2020.e03779

Ejemplares similares